Results 21 to 30 of about 179,020 (284)

Expanding Pharmacists’ Role in the Management of Non-Alcoholic Fatty Liver Disease

Pharmacy, 2023
Non-alcoholic fatty liver disease (NAFLD) stands as an increasingly pressing global health challenge, underscoring the need for timely identification to facilitate effective treatment and prevent the progression of chronic liver disorders.
Majid Mufaqam Syed-Abdul
doaj   +1 more source

Predisposing and precipitating risk factors for delirium in gastroenterology and hepatology: Subgroup analysis of 718 patients from a hospital-wide prospective cohort study

Frontiers in Medicine, 2022
Background and AimsDelirium is the most common acute neuropsychiatric syndrome in hospitalized patients. Higher age and cognitive impairment are known predisposing risk factors in general hospital populations.
Florian F. Hildenbrand, Florian F. Hildenbrand, Fritz R. Murray, Fritz R. Murray, Roland von Känel, Ansgar R. Deibel, Philipp Schreiner, Jutta Ernst, Carl M. Zipser, Carl M. Zipser, Soenke Böettger   +10 more
doaj   +1 more source

International Hepatology

Journal of Hepatology, 2010
COMMENTARY ONTbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation.Lüdtke TH, Christoffels VM, Petry M, Kispert A. Hepatology 2009 Mar;49:969–78, PMID: 19140222. Reprinted with permission of John Wiley & Sons, Inc.
Glaser, Shannon S., Alpini, Gianfranco
openaire   +2 more sources

Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease

eLife, 2019
Recent studies have identified a genetic variant rs641738 near two genes encoding membrane bound O-acyltransferase domain-containing 7 (MBOAT7) and transmembrane channel-like 4 (TMC4) that associate with increased risk of non-alcoholic fatty liver ...
Robert N Helsley, Venkateshwari Varadharajan, Amanda L Brown, Anthony D Gromovsky, Rebecca C Schugar, Iyappan Ramachandiran, Kevin Fung, Mohammad Nasser Kabbany, Rakhee Banerjee, Chase K Neumann, Chelsea Finney, Preeti Pathak, Danny Orabi, Lucas J Osborn, William Massey, Renliang Zhang, Anagha Kadam, Brian E Sansbury, Calvin Pan, Jessica Sacks, Richard G Lee, Rosanne M Crooke, Mark J Graham, Madeleine E Lemieux, Valentin Gogonea, John P Kirwan, Daniela S Allende, Mete Civelek, Paul L Fox, Lawrence L Rudel, Aldons J Lusis, Matthew Spite, J Mark Brown   +32 more
doaj   +1 more source

Imaging of chemotherapy-induced liver toxicity: an illustrated overview

Hepatic Oncology, 2021
Chemotherapy is a potential cause of focal and diffuse hepatobiliary lesions. Many of these lesions may be demonstrated on imaging, especially computed tomography and MRI.
Giovanni Brondani Torri, Matheus Dorigatti Soldatelli, Gustavo Felipe Luersen, Caroline Lorenzoni Almeida Ghezzi   +3 more
doaj   +1 more source

Spontaneous splenic rupture associated with Q fever and portal hypertension: A case report

Frontiers in Medicine
Spontaneous splenic rupture (SSR) is an exceptionally rare and life-threatening condition, with its pathophysiology remaining poorly understood. This report describes the first documented case of SSR in a patient with Q fever infection and underlying ...
Cecil Mustafiz, Cecil Mustafiz, Deloshaan Subhaharan, Deloshaan Subhaharan, Daniel Chorley, Tariq Masood   +5 more
doaj   +1 more source

Soaring rates of alcohol‐related hepatitis in the latter phase of the COVID‐19 pandemic: A new normal?

JGH Open, 2023
Background Studies have reported that the COVID‐19 pandemic has led to an increase in alcohol consumption and alcohol‐associated health problems in the general population.
Aalam Sohal, Sameeha Khalid, Victoria Green, Jeffrey Hagino, Hunza Chaudhry, Alakh Gulati, Marina Roytman   +6 more
doaj   +1 more source

THE ROLE OF DIGESTIVE MANIFESTATIONS IN COVID-19 MORTALITY: EVIDENCES FROM BRAZIL’S FIRST EPIDEMIC WAVE [PDF]

Arquivos de Gastroenterologia
Context: COVID-19, caused by SARS-CoV-2, is primarily characterized by respiratory symptoms but also significantly affects the gastrointestinal (GI) tract and liver.
Elvis Paim FERREIRA, Mariana da Silva ARBUÉS, André Castro LYRA, Lourianne Nascimento CAVALCANTE   +3 more
doaj   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Liver Disease Associated with Inflammatory Bowel Disease

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Inflammatory Bowel Disease (IBD) is a chronic condition characterized by persistent inflammation of the gastrointestinal tract, comprising ulcerative colitis (UC) and Crohn’s disease (CD). While the current global incidence of IBD exceeds 0.3% in Western
Juferdy Kurniawan, Refael Alfa Budiman
doaj   +1 more source